Skip to content

Drug interactions

Fostemsavir + Ledipasvir-sofosbuvir

Severity: Minor

Fostemsavir and Ledipasvir-sofosbuvir: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fostemsavir's active moiety inhibits BCRP, and ledipasvir and sofosbuvir are BCRP substrates, so their exposure may increase modestly. The antivirals are generally well tolerated, so clinical impact is expected to be limited.

What this interaction means in plain words

Fostemsavir and Ledipasvir-sofosbuvir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Fostemsavir belongs to Anti Virals; Ledipasvir-sofosbuvir belongs to Anti Virals.

Evidence level: Low

Why it happens

BCRP inhibition by temsavir may raise intestinal absorption of ledipasvir and sofosbuvir.

What to do

Coadministration is generally acceptable; monitor for adverse effects of the HCV regimen without dose changes.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fostemsavir and Ledipasvir-sofosbuvir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fostemsavir with Ledipasvir-sofosbuvir?

MediHelp rates the interaction as minor. Fostemsavir and Ledipasvir-sofosbuvir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Fostemsavir's active moiety inhibits BCRP, and ledipasvir and sofosbuvir are BCRP substrates, so their exposure may increase modestly. The antivirals are generally well tolerated, so clinical impact is expected to be limited.

How serious is the interaction between Fostemsavir and Ledipasvir-sofosbuvir?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Coadministration is generally acceptable; monitor for adverse effects of the HCV regimen without dose changes.

What other medicines interact with Ledipasvir-sofosbuvir?

MediHelp also lists interactions of Ledipasvir-sofosbuvir with, for example, Fosphenytoin, Phenobarbital, Phenytoin. The full list is on the Ledipasvir-sofosbuvir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in